Changes in Volume of Distribution in the Elderly

Age-Related Body Composition Changes

• Body fat mass increases while total body water decreases with aging, significantly altering drug distribution patterns 1, 2
• The increased proportion of body fat leads to a larger volume of distribution for lipophilic drugs, resulting in prolonged half-life of these medications 2

Impact on Lipid-Soluble Medications

• Highly lipophilic drugs have an increased volume of distribution and prolonged half-life in elderly patients 2, 3
• Potential drug accumulation with repeated dosing can occur due to the increased distribution volume of lipophilic drugs 1, 2

Clinical Implications

• Dosing adjustments may be necessary for lipophilic medications in elderly patients to account for altered pharmacokinetics 1
• Maintenance doses may need to be reduced and dosing intervals potentially extended to prevent accumulation 2
• Benzodiazepines are particularly affected by these changes, with increased sensitivity and prolonged effects in elderly patients 4, 2

Other Age-Related Pharmacokinetic Changes

• Decreased hepatic blood flow affects metabolism of highly extracted drugs 2
• Reduced renal function affects drug elimination, particularly for water-soluble medications 1, 2
• Decreased plasma albumin levels can increase free drug concentrations of highly protein-bound medications 2, 3

Monitoring Considerations

• Consider monitoring drug levels when available and clinically indicated 2